A 26-WEEK STUDY OF EFFICACY AND SAFETY OF DELAYED-RELEASE PREDNISONE IN NEWLY DIAGNOSED CASES OF GIANT CELL ARTERITIS: AN INTERIM ANALYSIS

被引：0
|
作者：
Raine, Charles [1 ]
Maw, Win [1 ]
Williams, Mark [1 ]
Gayford, Dawn [1 ]
Mapplebeck, Sarah [1 ]
Mackerness, Craig [1 ]
Dasgupta, Bhaskar [1 ]
机构：
[1] Southend Univ Hosp NHS Fdn Trust, Dept Rheumatol, Westcliff On Sea, Essex, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
TEMPORAL ARTERITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页码：7 / 8
页数：4
相关论文
共 50 条
  • [21] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis using a composite measure of disability: Integrated analysis of the Phase 3 defines and confirms studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert J.
    Potts, James
    Soman, Teesta
    Marantz, Jing
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 155 - 156
  • [22] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: eight-year follow-up of an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Yang, L.
    Taylor, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 313 - 314
  • [23] Efficacy of Delayed-release Dimethyl Fumarate at Seven-Year Follow-up in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Xiao, James
    Taylor, Catherine
    NEUROLOGY, 2017, 88
  • [24] Longer-Term Follow-Up of the Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert
    Zhang, Annie
    Taylor, Catherine
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [25] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing- remitting multiple sclerosis using a composite measure of disability-Integrated analysis of the phase 3 define and confirm studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert J.
    Potts, James
    Marantz, Jing L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP3 - NP4
  • [26] Relationship Between Morning Stiffness Duration and Severity, Pain Intensity, and Measures of Disease Activity in a 12 Week Efficacy Study of a Modified (Delayed-Release) Prednisone Plus Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis.
    Buttgereit, Frank
    Kirwan, John R.
    Saag, Kenneth G.
    Alten, Reike
    Grahn, Amy
    Rice, Patricia
    Boers, Maarten
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S544 - S545
  • [27] Interim analysis of the non-interventional MOMENT II study - efficacy and safety of Nilotinib in routine clinical management of newly diagnosed Ph plus CML patients in chronic phase
    Sauer, A.
    Lathan, B.
    Blumenstengel, K.
    Gabrysiak, T.
    Tebbe, S.
    Meincke, M.
    Frank, O.
    Tesch, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 84 - 84
  • [28] Results of an interim analysis of the non-interventional MOMENT II-study for determining efficacy and safety of Nilotinib in newly diagnosed Ph plus CML patients in chronic phase
    Lathan, B.
    Sauer, A.
    Tebbe, S.
    Ulshoefer, T. M.
    Blumenstengel, K.
    Gabrysiak, T.
    Lange, E.
    Losem, C.
    Schmidt, E.
    Meincke, M.
    Frank, O.
    Tesch, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 63 - 63
  • [29] Efficacy and safety of Nilotinib in routine clinical management of newly diagnosed Ph plus CML patients in chronic phase - interim analysis of the non-interventional MOMENT II study
    Lathan, B.
    Sauer, A.
    Titgemeyer, J.
    Groschek, M.
    Gabrysiak, T.
    Hutzschenreuther, U.
    Tebbe, S.
    Meincke, M.
    Frank, O.
    Tesch, H.
    ONKOLOGIE, 2013, 36 : 62 - 62
  • [30] Efficacy and safety of delayed-release dimethyl fumarate in treatment-naive Japanese patients with relapsing-remitting multiple sclerosis: A post-hoc subgroup analysis of the apex study
    Mori, M.
    Ohashi, T.
    Onizuka, Y.
    Hiramatsu, K.
    Hase, M.
    Yun, J.
    Ling, Y.
    Torii, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 795 - 796
12345